Abstract:BACKGROUND. Glycogen synthase kinase 3 (GSK-3) has been regarded as a potential therapeutic target for multiple human cancers. We previously reported that suppression of GSK-3 activity with lithium chloride (LiCl) or small chemical inhibitors impaired cellular DNA synthesis and reduced cell proliferation in prostate cancer cells. Therefore, in this study, we extended this in vitro findings to in vivo settings in order to establish a proof of concept that inhibition of GSK-3 activity is feasible in suppressing tumor growth of prostate cancer in vivo. METHODS. In this study, we used three GSK-3 inhibitors, LiCl, TDZD-8, and L803-mts, which are structurally unrelated and non-ATP competitive. Human prostate cancer cell lines PC-3 and C4-2 were used for nude mouse xenograft models. The autochthonous transgenic prostate cancer TRAMP mice were used for testing GSK-3 inhibitor's effect on tumor development. Anti-Ki-67 and BrdU immunohistochemistry was used to determine cell proliferation. The pE2F-TA-LUC (E2F-LUC) luciferase reporter assay and gene specific small interferencing RNA technique were used to examine C/EBP involvement in GSK-3 inhibitor-induced E2F-1 suppression. RESULTS. Using mouse xenograft models, we demonstrated that LiCl and TDZD-8 significantly suppressed tumor development and growth of subcutaneous xenografts derived from human prostate cancer cells. Similarly, in the TRAMP mice, TDZD-8 and L803-mts reduced the incidence and tumor burden in the prostate lobes. Consistent with our previous in vitro findings, GSK-3 inhibitors significantly reduced BrdU incorporation and Ki67-positive cells in xenograft tumors and mouse cancerous prostates compared to the control. Further analysis revealed that following GSK-3 inhibition, C/EBP alpha, a negative cell cycle regulator, was remarkably accumulated in xenograft tumors or in cultured prostate cancer cells. Meanwhile, knocking down C/EBP alpha expression abolished GSK-3 inhibition-induced suppression of E2F1 transactivation, suggesting that C/EBP alpha accumulation is involved in GSK-3 inhibition-induced anti-tumor effect. CONCLUSION. Taken together, these results suggest that GSK-3 inhibition has the potential as a therapeutic strategy for prostate cancer intervention, although further pre-clinical and clinical testing are desirable. Prostate 71: 835-845, 2011. (C) 2010 Wiley-Liss, Inc.

Retracted: Guggulsterone Inhibits Prostate Cancer Growth Via Inactivation of Akt Regulated by ATP Citrate Lyase Signaling.

Effect of laminin tyrosine-isoleucine-glycine-serine-arginine peptide on the growth of human prostate cancer (PC-3) cells in vitro.

Compound K is a Potential Clinical Anticancer Agent in Prostate Cancer by Arresting Cell Cycle.

Guggulsterone induces apoptosis and inhibits lysosomal-dependent migration in human bladder cancer cells

Z-Guggulsterone Inhibits Tumor Cell Proliferation, Migration in Vitro and Tumor Growth in Vivo Through PTEN/Akt/COX-2 Signaling Pathway

Guggulsterone Induces Apoptosis of Human Hepatocellular Carcinoma Cells Through Intrinsic Mitochondrial Pathway

Inhibitory activity of apogossypol in human prostate cancer in vitro and in vivo.

Astragalus Extract Inhibits Proliferation but Enhances Apoptosis in Gastric Cancer.

Protein Expression Profiling Identifies Key Proteins and Pathways Involved in Growth Inhibitory Effects Exerted by Guggulsterone in Human Colorectal Cancer Cells

Suppression of Glycogen Synthase Kinase 3 Activity Reduces Tumor Growth of Prostate Cancer in Vivo.

Apogossypolone, a Novel Inhibitor of Antiapoptotic Bcl-2 Family Proteins, Induces Autophagy of PC-3 and LNCaP Prostate Cancer Cells in Vitro

Z-Guggulsterone Induces Apoptosis in Gastric Cancer Cells through the Intrinsic Mitochondria-Dependent Pathway

Inhibition Of Proliferation Of Prostate Cancer Cell Line, Pc-3, In Vitro And In Vivo Using (-)-Gossypol

Inhibitory Effect of a New Gossypol Derivative Apogossypolone (apog2) on Xenograft of Human Prostate Cancer Cell Line PC-3

Ginkgolic Acid Suppresses the Development of Pancreatic Cancer by Inhibiting Pathways Driving Lipogenesis.

The Inhibitory Effects of Gossypol on Human Prostate Cancer Cells-Pc3 Are Associated with Transforming Growth Factor Beta1 (tgfbeta1) Signal Transduction Pathway.

AKT, a Key Transmitter of HIF-1α and AR Signaling Pathways, Has a Critical Role in the Apigetrin-Mediated Anti-Cancer Effects in Prostate Cancer Cells

Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation

Gambogenic acid induces apoptosis and autophagy through ROS‐mediated endoplasmic reticulum stress via JNK pathway in prostate cancer cells

Pentagalloyl Glucose (PGG) Exhibits Anti-Cancer Activity against Aggressive Prostate Cancer by Modulating the ROR1 Mediated AKT-GSK3β Pathway

Ginkgetin induces apoptosis via activation of caspase and inhibition of survival genes in PC-3 prostate cancer cells